Gene · 6708
Papers1,813
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,813
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RHOA-regulated IGFBP2 promotes invasion and drives progression of BCR-ABL1 chronic myeloid leukemia. | Haematologica | 2023 | 35833297 | PubTator, text mining | PubMed |
| Prognostic features and comprehensive genomic analysis of NF1 mutations in EGFR mutant lung cancer patients. | Cancer Med | 2023 | 35702826 | PubTator, text mining | PubMed |
| Comprehensive analyses indicated the association between m6A related long non-coding RNAs and various pathways in glioma. | Cancer Med | 2023 | 35668574 | PubTator, text mining | PubMed |
| A Novel SPTA1 Mutation in a Patient with Hereditary Spherocytosis without a Family History and Coexisting Gilbert's Syndrome. | Intern Med | 2023 | 35650129 | PubTator, text mining | PubMed |
| Persisting Type 2 Endoleaks Following EVAR for AAA Are Associated With AAA Expansion. | J Endovasc Ther | 2023 | 35236157 | PubTator, text mining | PubMed |
| The first case of novel variants of the FSHR mutation causing primary amenorrhea in 2 siblings in Korea. | Ann Pediatr Endocrinol Metab | 2023 | 35038834 | PubTator, text mining | PubMed |
| Next-generation sequencing identified somatic alterations that may underlie the etiology of Chinese papillary thyroid carcinoma. | Eur J Cancer Prev | 2023 | 31724970 | PubTator, text mining | PubMed |
| Exome-Based Trio Analysis for Diagnosis of the Cause of Congenital Severe Hemolytic Anemia in a Child. | Transfus Med Hemother | 2022 | 37969868 | PubTator, text mining | PubMed |
| Identification and Validation of a Prognostic Signature Based on Methylation Profiles and Methylation-Driven Gene DAB2 as a Prognostic Biomarker in Differentiated Thyroid Carcinoma. | Dis Markers | 2022 | 37223105 | PubTator, text mining | PubMed |
Comprehensive genomic profiling of upper tract urothelial carcinoma and urothelial carcinoma of the bladder identifies distinct molecular characterizations with potential implications for targeted therapy & immunotherapy. | Front Immunol | 2022 | 36818471 | PubTator, text mining | PubMed |
| An integrated analysis of the cancer genome atlas data discovers a hierarchical association structure across thirty three cancer types. | PLOS Digit Health | 2022 | 36812605 | PubTator, text mining | PubMed |
| EDEM2 is a diagnostic and prognostic biomarker and associated with immune infiltration in glioma: A comprehensive analysis. | Front Oncol | 2022 | 36727065 | PubTator, text mining | PubMed |
| Chondrosarcoma with Target-Like Chondrocytes: Update on Molecular Profiling and Specific Morphological Features. | Folia Biol (Praha) | 2022 | 36689318 | PubTator, text mining | PubMed |
| A study of gene variation in All-RAS wild-type metastatic colorectal cancer and its correlation with cetuximab. | J Gastrointest Oncol | 2022 | 36636055 | PubTator, text mining | PubMed |
| Superporous acrylic acid and HPMC hydrogels of mefenamic acid: Formulation, characterization and optimization by central composite design. | Front Bioeng Biotechnol | 2022 | 36588944 | PubTator, text mining | PubMed |
| Which qualities should built environment possess to ensure satisfaction of higher-education students with remote education during pandemics? | Build Environ | 2022 | 36568651 | PubTator, text mining | PubMed |
| The 3-O sulfation of heparan sulfate proteoglycans contributes to the cellular internalization of tau aggregates. | BMC Mol Cell Biol | 2022 | 36564747 | PubTator, text mining | PubMed |
| Coagulation potential and the integrated omics of extracellular vesicles from COVID-19 positive patient plasma. | Sci Rep | 2022 | 36564503 | PubTator, text mining | PubMed |
| Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases. | JTO Clin Res Rep | 2022 | 36561283 | PubTator, text mining | PubMed |
| Cross-Linking and Functional Analyses for Dimerization of a Cysteine Mutant of Glycine Transporter 1. | Int J Mol Sci | 2022 | 36555800 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6708/papers?page=14